Speeches by Burton-Sampson.

“I thank the Prime Minister for his measured response so far. I have spoken to former constituents and friends who are British expats in the UAE. While they feel confident that the local Government there are doing all that they can to protect them, for clarity, will they too be considered for evacuation by the FCDO shou…”

“You are talking about implications counselling; does the counselling include the possibility of the egg donor discovering that they may have a genetic condition?”

“Is there adequate time given to counsellors?”

“Following on from that point, would the counsellor within a clinic be a trained counsellor or could it be a clinician who is not necessarily trained in the area of counselling but is giving some guidance?”

“I have some questions for you, Angela, concerning counselling. What does good counselling practice for both egg donation and freezing look like for you, and how widely is that implemented? Going on from that, are counsellors given adequate time and resources to deliver good counselling?”

“Is follow-up counselling widely available? It links in, really.”

“How widely is follow-up counselling available, and should clinics be required to offer more than one pre-treatment session?”

“This is the final question from me: how well do you think clinics integrate the implications of commercially available DNA testing into their counselling? Do you think there should be national guidance updated to reflect the technological realities that exist now?”

“Do you think counselling should be mandatory?”

“To what extent is one benefit of CIISA that it can spot patterns of behaviour that individual companies may be unaware of due to people moving around the industry?”

“Zelda, do you have anything to add?”

“Jen, questions for this section are predominantly for you, but Zelda, I am interested in your views if you want to jump in. It is looking at the engagement that you have had from across the creative industries with CIISA so far, particularly regarding training and standards. Do you have a particular level of engagement…”

“Obviously, this inquiry is very much around misogyny in music, but it is interesting that both of you have referred to other areas where people may be targeted with NDAs and the like where there may be a level of abuse. I think of young actors—the profession I originally trained in—and I know there were interesting beh…”

“That is interesting, and it will be good to get that information further down the line. Is there a pattern to the type of people who support you, or is it very much down to the personality of the leader or the leadership team?”

“Just on that, two follow-up questions, if I may? Obviously, the people who come to you and want to be recognised or be part of the scheme that you offer are probably the good people, the good leaders, the transparent leaders. Is there a concern that maybe those who should be monitored by you guys are not being monitore…”

“Obviously, those are four areas of the creative industry that you cover. There are others, such as gaming, art and so on. Is there a problem within those areas of the industry as well? Obviously, you cannot pick up everything.”

“Baroness Merron, do you think menstrual disorders should have their own research categories separate from the current broader category of reproductive health and childbirth?”

“We are now going to focus on, I guess, the core of this session, which is about menstrual disorders and gynaecological health. Baroness Merron, is there anything else that you have not mentioned so far? I know you have started to focus on some aspects in relation to both those areas, but is there anything else that you…”

“Absolutely. If I can just add, given some findings of this Committee and Dr Mansour—you have been to some evidence sessions—there are clearly challenges and gaps in provision for menstrual and gynaecological healthcare for women that we all want to address. I guess what we are asking is should this be a thematic priori…”

“Perhaps, Sue, if you could focus a little more on what those measurable outcomes look like.”